Tuesday, July 01, 2008
Teva receives FDA approval for generic anti-psychotic drug Risperdal
NEW YORK - Johnson & Johnson's blockbuster anti-psychotic drug Risperdal will face generic competition, as Teva Pharmaceutical Industries Ltd. on Monday became the first company to receive approval for a generic version. Israel-based Teva received U.S....More
Subscribe to:
Post Comments (Atom)
Posts
No comments:
Post a Comment